FDA.reportPublic FDA data

Jemperli 500 MG in 10 mL Injection

RxCUI
2539977
RxNorm name
Jemperli 500 MG in 10 mL Injection
Display name
Jemperli 500 MG in 10 mL Injection
Full name
Jemperli 500 MG in 10 mL Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761174Jemperlidostarlimab-gxly351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
095eab9f-545a-4f12-bfb7-19477fb901a5Jemperli 500 MG in 10 mL InjectionPSN14These highlights do not include all the information needed to use JEMPERLI safely and effectively. See full prescribing information for JEMPERLI. JEMPERLI (dostarlimab-gxly) injection, for intravenous use Initial U.S. Approval: 202120250902
095eab9f-545a-4f12-bfb7-19477fb901a510 ML Jemperli 50 MG/ML InjectionSY14These highlights do not include all the information needed to use JEMPERLI safely and effectively. See full prescribing information for JEMPERLI. JEMPERLI (dostarlimab-gxly) injection, for intravenous use Initial U.S. Approval: 202120250902
095eab9f-545a-4f12-bfb7-19477fb901a5Jemperli 500 MG per 10 ML InjectionSY14These highlights do not include all the information needed to use JEMPERLI safely and effectively. See full prescribing information for JEMPERLI. JEMPERLI (dostarlimab-gxly) injection, for intravenous use Initial U.S. Approval: 202120250902
095eab9f-545a-4f12-bfb7-19477fb901a510 ML dostarlimab-gxly 50 MG/ML Injection [Jemperli]SBD14These highlights do not include all the information needed to use JEMPERLI safely and effectively. See full prescribing information for JEMPERLI. JEMPERLI (dostarlimab-gxly) injection, for intravenous use Initial U.S. Approval: 202120250902